Dr. Brent Linden Fogel, MD

Dr. Fogel practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Fogel's NPI, 1629289178, was assigned on May 25, 2007. Dr. Fogel graduated from Medical College Of Wisconsin in 2003. Dr. Fogel holds California license A90493.

Dr. Fogel's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Fogel's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. The medical group on file is UCLA Neurology. Dmand AI also links Dr. Fogel to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fogel practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Fogel's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Fogel is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Fogel's licenses on file in 2 states: California and Illinois.

Dmand AI lists epilepsy, hereditary polyneuropathy and muscle disease among the conditions Dr. Fogel treats.

CMS data shows 71 Medicare services from Dr. Fogel across 2 procedure codes in 2024, all of them office visits, for 60 Medicare patients. Medicare paid $9,555 for them. Every service was in an office.

CMS counts 60 Medicare patients who saw Dr. Fogel in 2024. The largest group is 65 to 74, with 23 patients. 62% of them have high cholesterol, and 55% have high blood pressure. 40% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fogel's median patient age at 55, with 51% women.

In 2024, Dr. Fogel wrote 26 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $37 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Fogel for performance year 2024, reported as part of a group. Dr. Fogel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fogel as offering telehealth.

Dmand AI links 33 papers to Dr. Fogel, published from 2008 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Exome. Dr. Fogel has published most often in Ann Neurol. Dr. Fogel's most frequent co-authors are Susan Lee Perlman, MD, Joshua Deignan, PhD and David R. Lynch.

CMS Open Payments shows 3 general payments to Dr. Fogel from 1 drug or device company from 2020 to 2022. Education make up the largest share, 100% of the total. Travere Therapeutics, Inc. paid the most, $2.

Dr. Fogel graduated from Medical College Of Wisconsin in 2003. Dr. Fogel is a member of AAN.

Dr. Fogel is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.